Puma Biotechnology Inc Share Price OTC Bulletin Board
Equities
PBYI
US74587V1070
Biotechnology & Medical Research
Sales 2024 * | 219M 18.29B | Sales 2025 * | 225M 18.79B | Capitalization | 172M 14.34B |
---|---|---|---|---|---|
Net income 2024 * | 10M 835M | Net income 2025 * | 15M 1.25B | EV / Sales 2024 * | 0.78 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
14.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.6% |
Latest transcript on Puma Biotechnology Inc
Managers | Title | Age | Since |
---|---|---|---|
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/10/15 |
Maximo Nougues
DFI | Director of Finance/CFO | 55 | 05/18/05 |
Alvin Wong
CTO | Chief Tech/Sci/R&D Officer | 71 | 01/13/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Miller
BRD | Director/Board Member | 67 | 23/18/23 |
Jay Moyes
BRD | Director/Board Member | 70 | 27/12/27 |
Alan Auerbach
CEO | Chief Executive Officer | 54 | 15/10/15 |
1st Jan change | Capi. | |
---|---|---|
+51.85% | 59.28B | |
+41.42% | 40.94B | |
-5.25% | 40.17B | |
-5.16% | 28.69B | |
+12.79% | 26.63B | |
-20.18% | 18.89B | |
+30.88% | 12.46B | |
+0.61% | 12.42B | |
+25.06% | 12.26B |